Zieve's syndrome

Zieve's syndrome
Classification and external resources
Specialty gastroenterology
ICD-10 K70.0
ICD-9-CM 571.1

Zieve's syndrome is an acute metabolic condition that can occur during withdrawal from prolonged alcohol abuse. It is defined by hemolytic anemia (with spur cells and acanthocytes), hyperlipoproteinaemia (excessive blood lipoprotein), jaundice (elevation of unconjugated bilirubin), and abdominal pain.[1] The underlying cause is liver delipidization. This is distinct from alcoholic hepatitis which, however, may present simultaneously or develop later.

Diagnosis of Zieve's syndrome should be considered in alcoholic (especially after an episode of binge drinking) with an elevation of unconjugated bilirubin and without obvious sigs of gastrointestinal bleeding.[2]

Pathogenesis

The proposed mechanism of the characteristic haemolytic anaemia in Zieve's syndrome is due to alteration of the red cell metabolism, namely pyruvate kinase instability leaving them susceptible to circulating hemolysin such as lysolecithin.[3] Changes in membrane lipid compositions such as increased cholesterol and polyunsaturated fatty acid (PUFA) have been report during the hemolytic phase.[4]

Treatment

Definitive treatment for Zieve's syndrome is alcohol cessation.

History

Zieve's syndrome was initially described in 1958.[5] Dr Leslie Zieve described patients with a combination of alcoholic liver disease, hemolytic anemia and hypertriglyceridemia.

References

  1. ↑ Mehta, AB; N McIntyre (2004). Oxford Textbook of Clinical Hepatology. Oxford University Press. pp. 1786–1787. ISBN 0-19-262515-2.
  2. ↑ Shukla, Sandhya; Sitrin, Michael (2015-07-09). "Hemolysis in Acute Alcoholic Hepatitis: Zieve's Syndrome". ACG Case Reports Journal 2 (4): 250–251. doi:10.14309/crj.2015.75. ISSN 2326-3253. PMC 4508957. PMID 26203455.
  3. ↑ Melrose, W. D.; Bell, P. A.; Jupe, D. M.; Baikie, M. J. (1990-01-01). "Alcohol-associated haemolysis in Zieve's syndrome: a clinical and laboratory study of five cases". Clinical and Laboratory Haematology 12 (2): 159–167. ISSN 0141-9854. PMID 2208946.
  4. ↑ Kunz, F.; Stummvoll, W. (1970-10-01). "The significance of plasma phospholipids in Zieve syndrome". Blut 21 (4): 210–226. ISSN 0006-5242. PMID 5531666.
  5. ↑ Zieve, L (March 1958). "Jaundice, hyperlipemia and hemolytic anemia: a heretofore unrecognized syndrome associated with alcoholic fatty liver and cirrhosis". Annals of Internal Medicine 48 (3): 471–476. doi:10.7326/0003-4819-48-3-471. PMID 13521581.
This article is issued from Wikipedia - version of the Friday, March 18, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.